Biotech Scan

Scan

Biotech Scan

Scan symbols 40
AABBVALNYAMGNBEAMBIIBBMRNBNTXCOGTCRSPDHRDNADXCMEDITEXASGILDIBBIBBQILMNINCYIONSIQVISRGKYMRLABULEGNLLYMDTMRNANKTRNTLANVOPTGXRAREREGNRXRXSRPTTMOVRTXXBI
Watchlists 1
@biotech-scan
raw scan snapshot — prices as of scan date, not live 55 rows · screens, not recommendations ported fromresearch/classic/scans/2026-05-29-biotech-scan.md

EOW tape: gene editing names BEAM/EDIT/CRSP surging, NKTR crashing -24% 30D from monster status, LLY rips back near ATH (RSI 69.6), REGN/MDT in deep oversold territory.

Quick Snapshot

Signal Reading
Overall 🟡 Mixed-to-bullish — gene editing finally working, large pharma recouping April losses, but legacy devices (MDT, ISRG) still breaking down
Leaders LABU 3x ETF (+292% 1y, RSI 57), BEAM (+15% 7D, golden cross), CRSP (+12% 7D), ILMN (+28.6% 30D, RSI 78.6), LLY near ATH
Laggards NKTR (-24% 30D, RSI 28.8 — crashing from monster), REGN (RSI 27.3, -22% 3M), MDT (RSI 30.5, -24% 3M, deathcross)
Key insight NKTR reversal is the big story — was +137% 3M in April, now -24% 30D / RSI 28.8; REGN hits deep oversold at RSI 27.3 with -25% from 52wk high

Price Table

Stock Price RSI vs SMA20 7D% 30D% 3M% 52wkHi% Trend Signal
NKTR $64.88 28.8 ↓ -12.8% -4.42% -23.71% -5.09% -40.48% weak-down 🔍 Watch
REGN $614.78 27.3 ↓ -8.9% -2.48% -12.92% -22.14% -25.13% down ✅ Oversold Entry
MDT $73.81 30.5 ↓ -4.3% -3.99% -8.84% -24.15% -30.58% strong-down 🔍 Watch
ISRG $424.64 40.0 -3.1% -3.60% -7.20% -14.43% -29.68% strong-down 🔍 Watch
SRPT $17.87 43.8 -4.9% +1.52% -14.42% +9.50% -59.31% down ❌ Don't Buy
MRNA $47.19 44.2 -2.9% +0.23% +2.72% -10.71% -20.76% weak-down 🔍 Watch
RARE $23.94 48.3 -3.1% -1.61% -3.04% +4.00% -43.50% weak-up 🔍 Watch
PTGX $99.56 47.5 -1.3% -0.95% +0.60% +5.65% -7.68% weak-down 🔒 Hold
KYMR $81.42 46.5 -1.1% +2.12% +0.43% -9.63% -20.95% weak-down 🔍 Watch
ALNY $301.98 51.1 +2.1% +2.21% -2.43% -7.10% -39.06% strong-down 🔍 Watch
INCY $96.74 48.5 -0.8% +1.18% +1.54% -3.30% -13.85% strong-up 🔒 Hold
COGT $34.96 52.2 +2.1% +4.65% -2.32% -10.11% -20.05% weak-down 🔍 Watch
BNTX $95.95 53.8 +3.2% +1.50% -7.25% -10.73% -22.62% weak-up 🔍 Watch
GILD $134.43 51.9 +1.2% +2.26% +2.74% -9.89% -14.53% weak-down 🔍 Watch
AMGN $336.79 50.6 +1.7% -1.01% -2.00% -12.02% -13.93% weak-down 🔍 Watch
IONS $76.50 53.9 +1.2% +1.54% +2.33% -6.66% -11.81% strong-up 🔒 Hold
NTLA $14.07 54.8 +5.3% +8.65% +4.38% -8.87% -50.19% strong-up 🔍 Research
LEGN $27.16 53.3 -2.3% -4.63% +15.48% +47.29% -40.04% up 🔍 Watch
BIIB $196.00 56.4 +1.5% +1.35% +3.55% +4.23% -4.84% strong-up 🔒 Hold
IBBQ $29.84 56.0 +1.5% +1.12% +2.33% -0.07% -2.16% strong-up 🔒 Hold
IBB $172.18 55.6 +1.5% +1.59% +2.07% -0.93% -4.15% strong-up 🔒 Hold
LABU $195.30 57.1 +6.6% +6.74% +9.99% +15.22% -8.07% strong-up 🔒 Hold
VRTX $447.54 57.7 +2.6% +2.47% +4.72% -7.92% -11.89% strong-up 🔒 Hold
XBI $136.69 58.4 +2.5% +2.29% +4.08% +8.01% -1.80% strong-up 🔒 Hold
DNA $9.37 61.1 +7.1% +14.37% +10.76% +32.91% -46.70% weak-up ⚠️ Speculative
RXRX $3.59 61.9 +12.7% +13.25% +3.76% -1.10% -50.00% weak-up ⚠️ Speculative
BMRN $57.29 62.4 +7.8% -3.35% +6.27% -4.10% -13.56% up 🔍 Watch
ABBV $217.72 61.6 +3.7% -0.29% +3.03% -6.29% -11.07% up 🔒 Hold
NVO $45.58 61.6 +0.8% +1.27% +7.96% +25.15% -44.03% weak-up 🔍 Research
DHR $182.67 60.7 +6.6% +4.18% +2.08% -11.14% -24.77% weak-up 🔍 Watch
CRSP $56.18 60.2 +7.9% +11.91% +7.34% -7.55% -28.41% up 🔒 Hold
TMO $492.51 62.3 +7.3% +8.67% +2.83% -3.06% -23.52% weak-up 🔍 Watch
IQV $182.21 61.8 +6.1% +9.92% +15.05% +4.56% -26.25% weak-up 🔍 Watch
BEAM $32.93 61.9 +9.3% +15.38% +8.57% +14.78% -9.63% strong-up 🔒 Hold
EDIT $3.46 63.4 +17.0% +26.30% +15.33% +60.93% -23.74% strong-up ⚠️ Speculative
DXCM $73.74 69.2 +13.7% +0.31% +23.83% -0.05% -18.05% up ⚠️ Overbought
LLY $1105.00 69.6 +8.8% +5.63% +18.44% +8.74% -3.84% strong-up 🔒 Hold
EXAS $104.91 73.1 +1.2% +1.13% +1.02% +1.46% -0.07% strong-up ⚠️ Overbought
A $135.53 76.6 ↑ +16.5% +18.24% +17.29% +14.95% -28.20% up ⚠️ Overbought
ILMN $162.96 78.6 ↑ +12.9% +9.61% +28.58% +22.63% -1.46% strong-up ⚠️ Overbought

Tier Analysis

Capitulation (RSI < 30) — Potential Entry

  • NKTR ($64.88, RSI 28.8) — fell -24% 30D from monster status. Was +138% 3M in April. Sharp reversal. Thesis under review.
  • REGN ($614.78, RSI 27.3) — -22% 3M, -25% from 52wk high. Quality large-cap into deep oversold. Dupixent/pipeline intact.

Oversold (RSI 25–40) — Watch for Entry

  • MDT ($73.81, RSI 30.5) — medical devices in structural breakdown. Deathcross, -24% 3M, -31% from high. Yield support only.
  • ISRG ($424.64, RSI 40) — surgical robotics weakening, -14% 3M, -30% from high. Deathcross. Still the gold standard but re-rate happening.

Neutral / Building (RSI 40–60) — Core Zone

  • PTGX, INCY, IONS, BIIB, GILD, AMGN, IBB, IBBQ, XBI — biotech ETFs and stable mid-caps holding neutral to mild uptrend
  • NTLA, LEGN, CRSP — gene editing recovering after multi-year collapse; NTLA/CRSP golden cross
  • NVO — +25% 3M recovery from deep lows (-44% from ATH), deathcross still active, watch for confirmation

Overbought / Extended (RSI > 70) — Avoid Chasing

  • ILMN (RSI 78.6) — genomics ripping, +28.6% 30D; extended but thesis strong
  • A / Agilent (RSI 76.6) — +18% in a week, overbought, deathcross still active
  • EXAS (RSI 73.1) — near 52wk ATH, +140% 1y
  • EDIT (RSI 63.4, +61% 3M) — speculative gene editing bounce; micro-cap risk

Entry Zones

Stock Price Zone RSI 30D% Setup
REGN $614.78 <$640 27.3 ↓ -12.92% Deep oversold, quality franchise, dupixent monopoly, -25% from high
NKTR $64.88 <$70 28.8 ↓ -23.71% Monster crashing — wait for stabilization. Prior +500% 1y. High-risk re-entry.
MDT $73.81 — 30.5 ↓ -8.84% Structural breakdown (deathcross), yield trap risk. Avoid unless you see reversal catalyst.
ISRG $424.64 <$440 40.0 -7.20% Approaching entry but deathcross active. Watch for bottom formation.
NVO $45.58 $42-46 61.6 +7.96% Recovery attempt (+25% 3M off the lows). Still -44% from ATH. Deathcross active — needs confirmation.

Action Matrix

Action Stocks Why
✅ OVERSOLD ENTRY REGN RSI 27.3, quality pharma deep in capitulation, Dupixent intact
🔍 WATCH / RESEARCH NKTR, ISRG, MDT, NVO, BNTX, AMGN, GILD, ALNY Falling knives or recovery attempts — needs catalyst/confirmation
🔒 HOLD LLY, BIIB, INCY, IONS, VRTX, PTGX, ABBV, BEAM, CRSP, XBI, IBB, IBBQ, LABU Trends intact, thesis working
⚠️ OVERBOUGHT / AVOID ILMN, A, EXAS, DXCM Extended RSI, don't chase
⚠️ SPECULATIVE EDIT, NTLA, DNA, RXRX, LEGN, SRPT Deep drawdowns, no fundamentals, lottery-ticket risk
❌ DON'T BUY SRPT -59% from high, gene therapy collapse, no reversal signal

What Changed (vs April 28 scan)

  • NKTR reversal — was +138% 3M monster (+$83 price), now -24% 30D at $64.88 / RSI 28.8. Biggest story in the scan. Prior thesis must be re-verified.
  • LLY fully recovered — was RSI 37.6 at $874, now RSI 69.6 at $1,105. +18.4% 30D rip. GLP-1 thesis back on.
  • REGN new oversold — was neutral (RSI 45), now RSI 27.3 at $614. -22% 3M selloff. Contrast with LLY; Dupixent/KymAb pricing overhang?
  • BEAM/EDIT/CRSP surging — gene editing names all +8-27% 7D; golden crosses forming. Sector rotation into small biotech.
  • ILMN ripping — was RSI 47 at $126, now RSI 78.6 at $162. +28.6% 30D. Genomics thesis re-rating.
  • MDT continuing breakdown — RSI 30.5 now vs 32.6 in April; -24% 3M vs -18% prior. Structural devaluation.
  • A / Agilent — was RSI 44, now RSI 76.6; +18% in a week off lows. Extreme move; deathcross still active.
10 events
DateTypeEvent
Jun 16 ScanBiotech Scan Jun 26 ScanBiotech Scan Apr 26 ScanBiotech Scan Apr 28 ScanBiotech Scan Jul 7 ScanBiotech Scan Jul 11 ScanBiotech Scan Jul 17 ScanBiotech Scan Jul 25 ScanBiotech Scan Jul 28 ScanBiotech Scan Jul 31 ScanBiotech Scan

No direct external sources are attached to this read.